Morning Research on Agilent Technologies, Thermo Fisher Scientific, PerkinElmer, and Laboratory Corp. of America

Thu Mar 21, 2013 9:41am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130321:nPn3217901


LONDON,  March 21, 2013  /PRNewswire/ --

(ACA), which is the biggest overhaul of the healthcare industry in decades,
takes effect. The healthcare reform was upheld by the Supreme Court last year.
Healthcare companies, meanwhile, are evaluating the impact of the reform on
their businesses. While the ACA is likely to increase costs for companies such
as Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE:
TMO), PerkinElmer Inc. (NYSE: PKI), and Laboratory Corp. of America Holdings
(NYSE: LH) in the near-term, the increase in number of insured individuals could
benefit the healthcare industry in the long-term. Healthcare stocks ended mostly
higher on Wednesday, tracking gains in the broad market. StockCall has posted
free technical research reports on A, TMO, PKI, and LH and these can be accessed
by signing up at

http://www.stockcall.com/analysis

Shares of Agilent Technologies Inc. rose sharply yesterday. The stock ended the
day 1.67% higher at  $42.70  after hitting an intra-day high of  $42.78.
Agilent's shares are currently trading close to their 52-week high of  $46.28.
Year-to-date, the stock has gained 4.30%, underperforming the broad market. The
company's shares are currently facing resistance at around  $43. The stock's
MACD chart is currently giving bearish signals. Download the free report on A
upon registration at

http://www.StockCall.com/A032113.pdf   

Shares of Thermo Fisher Scientific Inc. edged higher in trading on Wednesday;
however, the gains were limited. The stock ended the day 0.21% higher at  $77.57
 after touching a 52-week high of  $78.04.  Thermo Fisher's  shares have had an
excellent run so far in 2013, gaining more than 21.80%. The stock has seen a
series of highs since the start of this year, which is a bullish signal. Volume
activity in the last two trading sessions, further confirms the positive trend.
The stock is currently trading above its 50-day and 200-day moving averages. TMO
technical report can be accessed for free by signing up at

http://www.StockCall.com/TMO032113.pdf

Shares of PerkinElmer Inc. ended nearly flat on Wednesday. The stock closed
0.06% higher at  $35.02  after touching an intra-day high of  $35.26.
PerkinElmer's shares are currently trading close to their 52-week high of 
$35.86. The stock currently has support at around  $35. The stock's MACD has
just crossed below the signal line, which suggests that market sentiment has
turned bearish on the stock. The company's shares have outperformed the broad
market so far this year, gaining more than 10.50%. The stock currently trades at
a P/E multiple of 58.37. The free report on PKI can be downloaded by signing up
now at

http://www.StockCall.com/PKI032113.pdf

Laboratory Corp. of America Holdings shares edged lower on Wednesday, extending
its losses for the week. The stock closed 0.14% lower at  $88.18, taking its
losses for the week to over 1%. The company's shares have underperformed the
broad market this year, gaining just 1.80%. The stock has been struggling to
break through  $90  resistance level. It currently has support at around  $87.
The stock's MACD has just crossed below the zero-line, which is a bearish
signal. The negative trend is further confirmed by recent volume activity. Free
report on LH can be accessed by registering at

http://www.StockCall.com/LH032113.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at

http://www.stockcall.com   

SOURCE  StockCall.com


Contact Person:William T. Knight, Email: info@stockcall.com , Contact Number:
+1-(646)-396-9857 (9:00 am EST - 01:30 pm EST)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.